Early Versus Late FDG-PET/CT in Bladder Cancer
NCT03065725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179
Last updated 2023-05-31
Summary
The aim of this study is to examine if late FDG-PET/CT images after intravenous FDG injection has a higher sensitivity and specificity in detecting local lymph node metastases in patients with muscle invasive BC than FDG-PET/CT images 60 minutes after FDG injection. The latter procedure has been used routinely until now.
Conditions
Interventions
- PROCEDURE
-
late FDG
In addition to regular FDG-PET/CT 60 minutes post injection, an extra scan 180 minutes post injection is made.
Sponsors & Collaborators
-
Jørgen Bjerggaard Jensen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-01
- Primary Completion
- 2019-08-13
- Completion
- 2022-01-01
Countries
- Denmark
Study Locations
More Related Trials
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
NCT00286832 ·Status: COMPLETED
-
Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer
NCT04053101 ·Status: COMPLETED
-
FDG-PET/CT Imaging as Early Predictor of DP
NCT02476734 ·Status: COMPLETED
-
[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases
NCT00670527 ·Status: UNKNOWN ·Phase: NA
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
PET/MRI and Biomarkers in Bladder Cancer
NCT01918592 ·Status: COMPLETED ·Phase: NA
-
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
NCT02287701 ·Status: COMPLETED ·Phase: NA
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Positron Emission Tomography in Detecting Testicle Cancer
NCT00045045 ·Status: COMPLETED ·Phase: NA
-
Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors
NCT01436591 ·Status: TERMINATED
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma
NCT05209750 ·Status: UNKNOWN ·Phase: NA
-
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
NCT00256490 ·Status: COMPLETED ·Phase: NA
-
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
NCT00612326 ·Status: COMPLETED
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)
NCT00754117 ·Status: COMPLETED
-
Comparison of FDG and FAPI in Patients With Various Types of Cancer
NCT04416165 ·Status: RECRUITING ·Phase: NA
-
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
NCT04838626 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
NCT00534989 ·Status: COMPLETED ·Phase: NA
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
PET CT Re-Planning NSCLC (4DCT-PET)
NCT03403127 ·Status: COMPLETED ·Phase: NA
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma
NCT05411250 ·Status: UNKNOWN
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED